Beth Weinberg
General Counsel en CARA THERAPEUTICS, INC. .
Perfil
Beth Weinberg currently works at CARA Therapeutics, Inc., as Senior Vice President-Regulatory Affairs.
Ms. Weinberg also formerly worked at Angion Biomedica Corp., as Vice President & Head-Regulatory and Metavant Sciences, Inc., as VP, Head-Regulatory Affairs & Quality.
Ms. Weinberg received her undergraduate degree from Butler University and undergraduate degree from Bradley University.
Cargos activos de Beth Weinberg
| Empresas | Cargo | Inicio |
|---|---|---|
| CARA THERAPEUTICS, INC. | General Counsel | - |
Antiguos cargos conocidos de Beth Weinberg.
| Empresas | Cargo | Fin |
|---|---|---|
| ANGN BIOM | General Counsel | - |
| Metavant Sciences, Inc. | General Counsel | - |
Formación de Beth Weinberg.
| Butler University | Undergraduate Degree |
| Bradley University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
| Metavant Sciences, Inc. |
- Bolsa de valores
- Insiders
- Beth Weinberg
